These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15966635)

  • 21. The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns.
    Gilson AM; Joranson DE
    J Pain Palliat Care Pharmacother; 2007; 21(4):21-4. PubMed ID: 18032312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for prescribers of controlled substances. A joint statement of the Drug Enforcement Administration and the DEA/Practitioners Working Committee.
    Ohio State Med J; 1981 May; 77(5):312-3. PubMed ID: 7254747
    [No Abstract]   [Full Text] [Related]  

  • 23. Dentistry: controlled substances and enforcement.
    Hankins HH
    Ark Dent J; 1979 Jun; 50(2):12-5. PubMed ID: 119520
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescriptions for Schedule II controlled substances: Drug Enforcement Administration, Justice. Notice of proposed rulemaking.
    Fed Regist; 1980 Apr; 45(70):24199-200. PubMed ID: 10246081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for prescribing of controlled substances.
    J Ky Med Assoc; 1981 Jan; 79(1):37-8. PubMed ID: 7217773
    [No Abstract]   [Full Text] [Related]  

  • 26. Why is the DEA hounding this doctor?
    Roosevelt M
    Time; 2005 Jul; 166(4):56-8. PubMed ID: 16075844
    [No Abstract]   [Full Text] [Related]  

  • 27. Completing the 'right to write'. Controlled substances prescribing.
    Peters S
    Adv Nurse Pract; 1999 Jan; 7(1):59-61. PubMed ID: 10030173
    [No Abstract]   [Full Text] [Related]  

  • 28. Cases involving discipline for inappropriate prescribing of controlled substances.
    Thexton AK
    WMJ; 2001; 100(5):30-4. PubMed ID: 11579798
    [No Abstract]   [Full Text] [Related]  

  • 29. DEA grants prescriber numbers to certain Massachusetts pharmacists.
    J Pain Palliat Care Pharmacother; 2011; 25(3):297-9. PubMed ID: 21998842
    [No Abstract]   [Full Text] [Related]  

  • 30. DEA regulation of controlled substances and listed chemicals.
    Gilbert JA
    Food Drug Law J; 2010; 65(3):623-30. PubMed ID: 24479244
    [No Abstract]   [Full Text] [Related]  

  • 31. Designation of oripavine as a basic class of controlled substance. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2007 Sep; 72(184):54208-10. PubMed ID: 17912784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clarification of registration requirements for individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2006 Dec; 71(231):69478-80. PubMed ID: 17171847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exemption from import/export requirements for personal medical use. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(177):55343-7. PubMed ID: 15366181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2007 May; 72(85):24532-4. PubMed ID: 17520775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schedule II controlled substances: an update and review.
    Helgeland D
    S D Med; 2008 May; 61(5):183, 185. PubMed ID: 18630030
    [No Abstract]   [Full Text] [Related]  

  • 38. Making it easier to read prescriptions.
    Farley D
    FDA Consum; 1995; 29(6):25-7. PubMed ID: 10143448
    [No Abstract]   [Full Text] [Related]  

  • 39. Prescribing issues grant report to the Board of Medical Examiners. II. Minnesota Medical Association.
    Minn Med; 1990 Aug; 73(8):36-42. PubMed ID: 2398844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescriptions for controlled substances.
    Oddis JA
    Resid Staff Physician; 1986 Apr; 32(4):10. PubMed ID: 10276510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.